Done Deal: Ligand Completes Merger of Pelthos Therapeutics With Channel Therapeutics
Ligand Pharmaceuticals has completed its previously announced merger between Pelthos Therapeutics Merger with Channel Therapeutics. Pelthos will commence trading on the NYSE American exchange under the new ticker symbol “PTHS” as of July 2, 2025. “With the successful closing of this merger and the launch of Pelthos as an independent, publicly traded biopharmaceutical company, we […]